跳至主要内容
临床试验/ACTRN12608000598381
ACTRN12608000598381招募中未知

Omega-3 fatty acid supplementation for symptoms of depression in patients with cardiovascular disease

Dr Geoffrey Schrader0 个研究点目标入组 250 人开始时间: 2008年12月1日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
250

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 75 Years(—)
性别
All

入选标准

  • (a)angiographically-documented coronary artery disease, defined as >50% stenosis in an epicardial coronary artery on selective coronary angiography.
  • (b)Co-morbid depression as determined by a score of greater than or equal to 16 on the Center for Epidemiologic Studies – Depression (CES-D) scale
  • (c)able to complete questionnaires in written English.

排除标准

  • (a) more than one fish meals per week
  • (b) currently using fish oil supplementation (>300mg eicosapentaenoic acid (EPA)+ docosahexaenoic acid (DHA)/day)

研究者

发起方
Dr Geoffrey Schrader

相似试验